Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
äŒæ¥ã³ãŒãAPDN
äŒç€ŸåBNB Plus Corp
äžå Žæ¥Aug 24, 2001
æé«çµå¶è²¬ä»»è
ãCEOãShorrock (Clay)
åŸæ¥å¡æ°46
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Aug 24
æ¬ç€Ÿæåšå°50 Health Sciences Drive
éœåžSTONY BROOK
蚌åžååŒæNASDAQ Capital Market Consolidated
åœUnited States of America
éµäŸ¿çªå·11790
é»è©±çªå·16312408800
ãŠã§ããµã€ãhttps://adnas.com/
äŒæ¥ã³ãŒãAPDN
äžå Žæ¥Aug 24, 2001
æé«çµå¶è²¬ä»»è
ãCEOãShorrock (Clay)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã